The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmurfit Kappa Regulatory News (SKG)

Share Price Information for Smurfit Kappa (SKG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,512.00
Bid: 3,510.00
Ask: 3,514.00
Change: 12.00 (0.34%)
Spread: 4.00 (0.114%)
Open: 3,516.00
High: 3,544.00
Low: 3,486.00
Prev. Close: 3,500.00
SKG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Smurfit Kappa Group plc

18 Apr 2018 15:20

RNS Number : 3492L
BlackRock Group
18 April 2018
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

BlackRock, Inc.

Company dealt in

Smurfit Kappa Group plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

€0.001 ordinary shares

Date of dealing

17 April 2018

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

12,239,718 (5.16%)

0 (0.00%)

(2) Derivatives (other than options)

34,469 (0.01%)

192,524 (0.08%)

(3) Options and agreements to purchase/sell

0 (0.00%)

138,000 (0.05%)

Total

12,274,187 (5.17%)

330,524 (0.13%)

       

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

       

 

Ap20

 

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Purchase

3,160

GBP 30.4663

Purchase

898

EUR 35.6200

Sale

2,063

GBP 30.6540

Sale

1,154

GBP 30.6721

Please note: there was also a Transfer Out of 1,004 Shares

 

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD

Reducing Short

1,209

EUR 35.3810

CFD

Reducing Short

217

EUR 35.5322

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

 

2. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. 

If none, this should be stated.

 

 

 

None

 

 

 

Is a Supplemental Form 8 attached? (Note 9) YES

 

Date of disclosure

18 April 2018

Contact name

James Michael

Telephone number

+44 20 7743 3650

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

 

Ap23

 

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS (Note 1)

 

Product name,

e.g. call option

Written, or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Call Option

Written

40,000

EUR

34.4605

European

02/05/2018

Call Option

Written

40,000

EUR

34.6286

European

09/05/2018

Call Option

Written

58,000

EUR

34.2203

European

23/05/2018

 

Notes

 

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2. For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEIPMBTMBABBLP
Date   Source Headline
12th Jan 20216:03 pmRNSNotice of Extraordinary General Meeting
12th Jan 20217:00 amRNSNotice of Results
30th Nov 20202:11 pmRNSTotal Voting Rights
20th Nov 20206:10 pmRNSDirector/PDMR Shareholding
20th Nov 20206:00 pmRNSSmurfit Kappa Group
20th Nov 20207:00 amRNSResult of Placing
19th Nov 20204:35 pmRNSLaunch of Placing
9th Nov 202012:15 pmRNSSmurfit Kappa raises Climate Change ambition
6th Nov 20203:09 pmRNSBlock listing Interim Review
4th Nov 20207:00 amRNSTrading Statement
30th Oct 20202:45 pmRNSDirectorate Change
19th Oct 20207:00 amRNSNotice of Results
1st Sep 20207:00 amRNSTotal Voting Rights
26th Aug 20205:05 pmRNSHolding(s) in Company
29th Jul 20207:00 amBUSHalf-year Report
14th Jul 20205:22 pmRNSHolding(s) in Company
7th Jul 202011:53 amRNSNotice of Results
10th Jun 20209:54 amRNSDirector/PDMR Shareholding
9th Jun 20202:45 pmRNSHolding(s) in Company
26th May 20202:03 pmRNSHolding(s) in Company
20th May 20203:08 pmRNSHolding(s) in Company
19th May 20203:32 pmRNSHolding(s) in Company
11th May 20207:00 amRNSBlock listing Interim Review
5th May 20204:32 pmRNSHolding(s) in Company
1st May 202010:00 amRNSHolding(s) in Company
30th Apr 20204:12 pmRNSTotal Voting Rights
30th Apr 20203:59 pmRNSResult of AGM
27th Apr 20205:28 pmRNSHolding(s) in Company
27th Apr 20204:53 pmRNSDisclosure of Rights Attached to Equity Shares
22nd Apr 20209:03 amRNSAGM Update
17th Apr 20203:00 pmRNSDirector/PDMR Shareholding
17th Apr 202011:16 amRNSDirector/PDMR Shareholding
15th Apr 20207:00 amBUSTrading Statement
27th Mar 20204:19 pmRNSNotice of AGM
23rd Mar 20203:08 pmRNSAnnual Financial Report
18th Mar 20207:39 amRNSHolding(s) in Company
16th Mar 20203:53 pmRNSHolding(s) in Company
12th Mar 20204:41 pmRNSSecond Price Monitoring Extn
12th Mar 20204:35 pmRNSHolding(s) in Company
12th Mar 20204:35 pmRNSPrice Monitoring Extension
12th Mar 20208:16 amRNSHolding(s) in Company
10th Mar 20208:48 amRNSHolding(s) in Company
5th Mar 20204:25 pmRNSHolding(s) in Company
4th Mar 20204:46 pmRNSHolding(s) in Company
2nd Mar 20203:31 pmRNSHolding(s) in Company
2nd Mar 202012:14 pmRNSDirector/PDMR Shareholding
28th Feb 20205:19 pmRNSTotal Voting Rights
20th Feb 20202:38 pmRNSHolding(s) in Company
20th Feb 20209:58 amRNSDirector/PDMR Shareholding
14th Feb 20207:00 amRNSEuronext Dublin Market Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.